Skip to main content
. 2014 Apr 14;14(4):e10330. doi: 10.5812/hepatmon.10330

Table 1. Effect of CMFE on Serum Profile in Rat (n = 6) a, b.

Treatment AST, U/L ALT, U/L ALP, U/L T-Protein, g/dL Albumin, g/dL
Control + olive oil 58.12 ± 5.52 43.86 ± 6.35 214.29 ± 4.83 7.85 ± 0.15 3.65 ± 0.06
1 mL/kg CCl 4 155.74 ± 4.21c 197.4 ± 5.05c 322.63 ± 10.98 c 5.83 ± 0.23 c 1.31 ± 0.08 c
200 mg/kg CMFE + CCl 4 101.82 ± 4.69 d 133.60 ± 5.59 d 248.97 ± 6.11 d 7.10 ± 0.11 d 2.20 ± 0.09 d
500 mg/kg CMFE + CCl 4 115.03 ± 2.96 d 116.87 ± 5.65 d 235.23 ± 5.24 d 7.25 ± 0.14 d 2.85 ± 0.12 d
100 mg/kg Silymarin + CCl 4 85.22 ± 3.52 d 72.92 ± 3.25 d 223.64 ± 5.23 d 7.91 ± 0.16 d 3.20 ± 0.09 d

a Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CCl4, carbon tetrachloride; CMFE, Cornus mas fruits extract.

b Data are presented in Mean ± SE.

c Indicates significance at P < 0.05 probability from control group.

d Indicates significance at P < 0.05 probability from CCl4 group.